ACX 375C
Alternative Names: ACX-375CLatest Information Update: 23 May 2024
At a glance
- Originator Acurx Pharmaceuticals
- Class Antibacterials
- Mechanism of Action DNA polymerase III inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Gram-positive infections